Literature DB >> 10194380

Subunit affinities and stoichiometries of the human papillomavirus type 11 E1:E2:DNA complex.

S F Chao1, W J Rocque, S Daniel, L E Czyzyk, W C Phelps, K A Alexander.   

Abstract

The association between the papillomavirus E1 and E2 proteins is an important regulatory interaction, imparting coordinated control of viral transcription and replication. Using fluorescence polarization, we have characterized the interactions between HPV-11 E1, HPV-11 E2, and DNA in solution at equilibrium. For these studies, two double-stranded fluorescein-labeled oligonucleotides were prepared. The first fluorescent oligonucleotide, designated Fl-E2BS and containing a single E2 binding-site palindrome (ACCGN6CGGT), was used to determine the affinity of E2 for its DNA binding site. HPV-11 E2 bound Fl-E2BS with an apparent Kd of 0.84 nM. Binding was saturable and consistent with a single class of noninteracting sites. The second oligonucleotide, designated Fl-E1E2BS, contained both E1 and E2 sites in sequence derived directly from the HPV-11 origin of replication. Under titration conditions identical to those used for Fl-E2BS, the E2 protein exhibited reduced affinity for Fl-E1E2BS (Kd > 100 nM). E1 binding to Fl-E1E2BS was of very low affinity. Addition of excess HPV-11 E1 to Fl-E1E2BS lowered the dissociation constant for the E2:Fl-E1E2BS interaction to 2 nM. This effect was not dependent upon ATP or magnesium ion. Fluorescence polarization and other data suggest formation of a complex containing six E1 molecules and a single dimer of E2 bound to a single Fl-E1E2BS oligonucleotide; E2 dissociation from the final complex did not occur. In summary, physical interaction between E1 and E2 increases the DNA binding affinity of each. The role of this energy coupling may be to promote origin-specific binding of both E1 and E2 to DNA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194380     DOI: 10.1021/bi982616v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Inhibition of DNA replication of human papillomavirus by artificial zinc finger proteins.

Authors:  Takashi Mino; Takeaki Hatono; Naoki Matsumoto; Tomoaki Mori; Yusuke Mineta; Yasuhiro Aoyama; Takashi Sera
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Human TATA binding protein inhibits human papillomavirus type 11 DNA replication by antagonizing E1-E2 protein complex formation on the viral origin of replication.

Authors:  Kelly A Hartley; Kenneth A Alexander
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Characterization of the minimal DNA binding domain of the human papillomavirus e1 helicase: fluorescence anisotropy studies and characterization of a dimerization-defective mutant protein.

Authors:  S Titolo; K Brault; J Majewski; P W White; J Archambault
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  Expression of the HPV11 E2 gene in transgenic mice does not result in alterations of the phenotypic pattern.

Authors:  Kerstin Leykauf; Kirsten Kabsch; Nikolaus Gassler; Lutz Gissmann; Angel Alonso; Johannes Schenkel
Journal:  Transgenic Res       Date:  2007-08-16       Impact factor: 2.788

5.  Identification of peptides that inhibit the DNA binding, trans-activator, and DNA replication functions of the human papillomavirus type 11 E2 protein.

Authors:  Su-Jun Deng; Kenneth H Pearce; Eric P Dixon; Kelly A Hartley; Thomas B Stanley; David C Lobe; Edward P Garvey; Thomas A Kost; Regina L Petty; Warren J Rocque; Kenneth A Alexander; Mark R Underwood
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  Gene- and protein-delivered zinc finger-staphylococcal nuclease hybrid for inhibition of DNA replication of human papillomavirus.

Authors:  Takashi Mino; Tomoaki Mori; Yasuhiro Aoyama; Takashi Sera
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.